News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
122 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (21249)
Month
January (2935)
February (2968)
March (2710)
April (2908)
May (3626)
June (2409)
July (2088)
August (2590)
September (2381)
October (3064)
November (3189)
December (2222)
Day
1 (247)
2 (149)
3 (118)
4 (61)
7 (125)
8 (120)
9 (108)
10 (98)
11 (60)
13 (8)
14 (122)
15 (104)
16 (130)
17 (119)
18 (31)
21 (88)
22 (113)
23 (192)
24 (172)
25 (121)
28 (197)
29 (201)
30 (224)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
7
8
9
10
11
13
14
15
16
17
18
21
22
23
24
25
28
29
30
Press Releases
Lucid Diagnostics Announces Closing of Public Offering of Common Stock
April 14, 2025
·
4 min read
FDA
FDA After the Storm: Drug Review Delays and Increased Executive Oversight Expected
After the gutting of the Department of Health and Human Services, fears mount about the future direction of the FDA—with regulatory experts predicting delays in drug approvals and greater influence of political appointees.
April 14, 2025
·
6 min read
·
Heather McKenzie
Press Releases
Resolutions of the Annual General Meeting
April 14, 2025
·
5 min read
Press Releases
Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering
April 14, 2025
·
5 min read
Press Releases
Nika Pharmaceuticals, Inc. (NIKA) Latest Developments
April 14, 2025
·
2 min read
Press Releases
Hamamatsu Photonics and Sirona Dx (SDX) Announce Strategic Partnership to Expand Technology Access Program (TAP)
April 14, 2025
·
3 min read
Press Releases
Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock
April 14, 2025
·
2 min read
Press Releases
Organogenesis Supports CMS’ Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness
April 14, 2025
·
2 min read
Press Releases
4DMT Announces New Employment Inducement Grants - April 11, 2025
April 14, 2025
·
2 min read
Press Releases
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 11, 2025
April 14, 2025
·
3 min read
Previous
2 of 13
Next
